drug
malathion
Marketedupdated 3mo agoby Suven Life Sciences Ltd
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 1, 2027
170 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Feb 1, 2027compositionUS 7560445170d
- Aug 14, 2026formulationUS 7977324
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 21m ago
Found something off?
comments(0)
5-min edit window · permanent after that